FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056540680> ?p ?o ?g. }

• W2056540680 endingPage "664" @default.
• W2056540680 startingPage "664" @default.
• W2056540680 abstract "To compare interleukin-1alpha (IL-1alpha)-induced degradation of nasal and articular cartilages in terms of proteoglycan loss and type II collagen cleavage, denaturation, and release; to examine the temporal relationship of these changes; and to investigate the effects of an inhibitor of collagenase 2 and collagenase 3 on these catabolic processes.Discs of mature bovine nasal and articular cartilages were cultured with or without human IL-1alpha (5 ng/ml) with or without RS102,481, a selective synthetic inhibitor of collagenase 2 and collagenase 3 (matrix metalloproteinase 8 [MMP-8] and MMP-13, respectively) but not of collagenase 1 (MMP-1). Immunoassays were used to measure collagenase-generated type II collagen cleavage neoepitope (antibody COL2-3/4C(short)) and denaturation (antibody COL2-3/4m), as well as total type II collagen content (antibody COL2-3/4m) in articular cartilage and culture media. A colorimetric assay was used to measure total proteoglycan concentration (principally of aggrecan) as sulfated glycosaminoglycans (sGAG).IL-1alpha initially induced a decrease in tissue proteoglycan content in nasal cartilage. A progressive loss of proteoglycan was noted during culture in articular cartilages, irrespective of the presence of IL-1alpha. In both cartilages, proteoglycan loss was followed by IL-1alpha-induced cleavage of type II collagen by collagenase, which was often reflected by increased denaturation. The inhibitor RS102,481 had no clear effect on the reduction in proteoglycan content (measured by sGAG) and collagen denaturation in either cartilage, but at 10 nM it inhibited the enhanced cleavage of type II collagen, partially in nasal cartilage and completely in articular cartilage.IL-1alpha-induced cleavage and denaturation of type II collagen is observed in both hyaline cartilages and is secondary to proteoglycan loss. It probably involves different collagenases, since there is no evidence of a rate-limiting role for collagenase 1 in articular cartilage, unlike the case for nasal cartilage. Inhibitors of this kind may be of value in the treatment of cartilage damage in arthritis. Also, the ability to detect the release of type II collagen collagenase-generated fragments from degraded cartilage offers the potential to monitor cartilage collagen damage and its control in vivo." @default.
• W2056540680 created "2016-06-24" @default.
• W2056540680 creator A5006114293 @default.
• W2056540680 creator A5043549670 @default.
• W2056540680 creator A5054427793 @default.
• W2056540680 creator A5072570750 @default.
• W2056540680 creator A5072584844 @default.
• W2056540680 creator A5072950182 @default.
• W2056540680 creator A5073577992 @default.
• W2056540680 creator A5083671090 @default.
• W2056540680 date "2000-03-01" @default.
• W2056540680 modified "2023-10-09" @default.
• W2056540680 title "Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase" @default.
• W2056540680 cites W1593295279 @default.
• W2056540680 cites W190369605 @default.
• W2056540680 cites W1964753544 @default.
• W2056540680 cites W1969179229 @default.
• W2056540680 cites W1971481363 @default.
• W2056540680 cites W1977837843 @default.
• W2056540680 cites W1979972616 @default.
• W2056540680 cites W1990000966 @default.
• W2056540680 cites W1997027978 @default.
• W2056540680 cites W2003867975 @default.
• W2056540680 cites W2004488501 @default.
• W2056540680 cites W2004554807 @default.
• W2056540680 cites W2017786610 @default.
• W2056540680 cites W2023560282 @default.
• W2056540680 cites W2029641981 @default.
• W2056540680 cites W2032255522 @default.
• W2056540680 cites W2043068076 @default.
• W2056540680 cites W2047636197 @default.
• W2056540680 cites W2087193732 @default.
• W2056540680 cites W2094875212 @default.
• W2056540680 cites W2098076093 @default.
• W2056540680 cites W2100837269 @default.
• W2056540680 cites W2138960046 @default.
• W2056540680 cites W2287771163 @default.
• W2056540680 cites W326021446 @default.
• W2056540680 cites W4830826 @default.
• W2056540680 doi "https://doi.org/10.1002/1529-0131(200003)43:3<664::aid-anr24>3.0.co;2-d" @default.
• W2056540680 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10728761" @default.
• W2056540680 hasPublicationYear "2000" @default.
• W2056540680 type Work @default.
• W2056540680 sameAs 2056540680 @default.
• W2056540680 citedByCount "154" @default.
• W2056540680 countsByYear W20565406802012 @default.
• W2056540680 countsByYear W20565406802013 @default.
• W2056540680 countsByYear W20565406802014 @default.
• W2056540680 countsByYear W20565406802015 @default.
• W2056540680 countsByYear W20565406802016 @default.
• W2056540680 countsByYear W20565406802017 @default.
• W2056540680 countsByYear W20565406802019 @default.
• W2056540680 countsByYear W20565406802020 @default.
• W2056540680 countsByYear W20565406802022 @default.
• W2056540680 crossrefType "journal-article" @default.
• W2056540680 hasAuthorship W2056540680A5006114293 @default.
• W2056540680 hasAuthorship W2056540680A5043549670 @default.
• W2056540680 hasAuthorship W2056540680A5054427793 @default.
• W2056540680 hasAuthorship W2056540680A5072570750 @default.
• W2056540680 hasAuthorship W2056540680A5072584844 @default.
• W2056540680 hasAuthorship W2056540680A5072950182 @default.
• W2056540680 hasAuthorship W2056540680A5073577992 @default.
• W2056540680 hasAuthorship W2056540680A5083671090 @default.
• W2056540680 hasBestOaLocation W20565406801 @default.
• W2056540680 hasConcept C105702510 @default.
• W2056540680 hasConcept C109523444 @default.
• W2056540680 hasConcept C126322002 @default.
• W2056540680 hasConcept C142724271 @default.
• W2056540680 hasConcept C153074725 @default.
• W2056540680 hasConcept C153911025 @default.
• W2056540680 hasConcept C181199279 @default.
• W2056540680 hasConcept C185592680 @default.
• W2056540680 hasConcept C189165786 @default.
• W2056540680 hasConcept C197534660 @default.
• W2056540680 hasConcept C202751555 @default.
• W2056540680 hasConcept C204787440 @default.
• W2056540680 hasConcept C2776050027 @default.
• W2056540680 hasConcept C2776164576 @default.
• W2056540680 hasConcept C2776729418 @default.
• W2056540680 hasConcept C2776747403 @default.
• W2056540680 hasConcept C2778311950 @default.
• W2056540680 hasConcept C2778394429 @default.
• W2056540680 hasConcept C2779335624 @default.
• W2056540680 hasConcept C2779851118 @default.
• W2056540680 hasConcept C2780550940 @default.
• W2056540680 hasConcept C2780644872 @default.
• W2056540680 hasConcept C2781013607 @default.
• W2056540680 hasConcept C2781403057 @default.
• W2056540680 hasConcept C3020332539 @default.
• W2056540680 hasConcept C38008103 @default.
• W2056540680 hasConcept C55493867 @default.
• W2056540680 hasConcept C71924100 @default.
• W2056540680 hasConcept C86803240 @default.
• W2056540680 hasConceptScore W2056540680C105702510 @default.
• W2056540680 hasConceptScore W2056540680C109523444 @default.
• W2056540680 hasConceptScore W2056540680C126322002 @default.
• W2056540680 hasConceptScore W2056540680C142724271 @default.
• W2056540680 hasConceptScore W2056540680C153074725 @default.

• next